Among patients with a 1-PSA ≥ 4 ng/mL, those with a decrease of approximately 18% or more from 1-PSA to 2-PSA had a significantly lower risk of developing prostate than those with no change between 1-PSA and 2-PSA. Here, KLK3 is linked to male reproductive organ cancer.